Molecule Name |
PE001021
|
Refractivity |
102
|
SMILES format |
COC1=C2C(C[C@H](C)[C@H](C)CC3=CC4=C(OCO4)C(OC)=C23)=CC2=C1OCO2
|
Resonant Structures |
1
|
TPSA |
55
|
ASA hydrophobic |
464
|
ASA polar |
122
|
Accessible Surface Area |
585
|
LogS |
-7
|
MW |
384
|
cLogP |
5
|
H-Acceptors |
6
|
H-Donors |
0
|
Ro5 violations |
1
|
DrugScore |
0
|
Druglikeness |
-2
|
Irritant |
none
|
Mutagenic |
none
|
Reproductive Effective |
none
|
Tumorigenic |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity 2 |
0.2251
|
Rat Acute Toxicity |
2
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2+
|
Caco-2 Permeability 2 |
2
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
CYP450 2C9 Substrate |
Non-substrate
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity 2 |
1
|
AMES Toxicity |
Non AMES toxic
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 2C19 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Inhibitor
|
CYP450 2D6 Inhibitor |
Inhibitor
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogens |
Non-carcinogens
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
High HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Carcinogenicity (Three-class) |
Non-required
|
Human Intestinal Absorption |
HIA+
|